Zhejiang Hospital 2022 Postdoctoral Recruitment Program Launched! Waiting For You to Join→

Postdoctoral Recruitment

Zhejiang Hospital

Hospital Introduction

Zhejiang Hospital, affiliated with the Health and Health Commission of Zhejiang Province, was founded in 1954 and became an affiliated hospital of Zhejiang University School of Medicine in December 2020. At present, it is a comprehensive hospital with medical treatment, teaching, scientific research, prevention and health care, including Lingyin hospital area and Sandun hospital area. It has Zhejiang Institute of Geriatrics, Zhejiang Key Laboratory of Geriatrics, Zhejiang Research Center for Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, etc. As a base for stroke screening and prevention of the National Health Commission, a core unit for collaborative innovation of the National Clinical Medical Research Center for Geriatric Diseases, a training base for the prevention and treatment of geriatric diseases in the province, and a teaching hospital of Zhejiang University and higher medical schools in the province, the hospital strives to create a synchronous clinical, scientific research and teaching development.

In order to cultivate a group of high-level medical research talents, we are now recruiting postdocs for the year 2022 worldwide, as follows.

Recruiting Demand

In 2022, we plan to recruit several postdocs.

Recruiting Requirements

1. Doctoral degree in clinical medicine, Chinese medicine, traditional Chinese and Western medicine, basic medicine, pharmacy, general medicine, immunology, microbiology, molecular biology, biochemistry, cell biology, bioinformatics, health management and other related fields.

2. Postdoctoral candidates should be no more than 35 years old, no more than 3 years after obtaining their PhD, with good character and good health.

3. Strong scientific research ability and good academic development potential, with preference given to those who have published one SCI paper as first author within the last three years.

4. Meet the requirements of the corresponding team and be able to work full-time in the hospital as a postdoctoral researcher.

Working period

The postdoctoral period is generally 2 years.

Remuneration

1. Annual salary of 300,000-350,000 (including basic salary, special subsidy and provident fund) during the postdoctoral period, foreigners, Hong Kong, Macao and Taiwan postdoctoral staff will have all kinds of insurance according to foreign affairs regulations, and the team can provide additional post allowance according to the applicant's academic level and work achievements, and the performance rewards achieved during the postdoctoral period can enjoy corresponding rewards according to the hospital's research performance rewards, plus year-end performance rewards if the assessment is excellent.

2. After entering the station, applicants can apply for appointment as assistant researcher, and those with outstanding performance can be specially appointed (associate) researcher after leaving the station; post-docs with excellent assessment can declare hospital career establishment (post system), title promotion and establishment of independent subject groups according to relevant hospital regulations.

3. Provide good scientific research conditions, encourage and support the declaration of postdoctoral funds and other national and local science and technology projects.

4. Enjoy the same treatment as the staff on staff: including meal allowance, union benefits, annual staff physical examination, etc.

5. Those who have no housing can apply to live in the talent apartment in the hospital (proof of no housing in Hangzhou city is required).

Recruitment Plan

Professor Yan Jing's Team

1

Mentor Profile

Chief physician, professor, doctoral supervisor, secretary of the Party Committee of Zhejiang Hospital, deputy director of the Critical Care Medicine Branch of the Chinese Medical Association, president of the Critical Care Medicine Committee of the Chinese Society of Geriatrics, director of the Critical Care Medicine Branch of Zhejiang Medical Association, president of the Critical Care Medicine Physicians Branch of Zhejiang Medical Association, former director of the Geriatrics Branch of Zhejiang Medical Association. He is the leader of National Key Clinical Specialties (Intensive Care Medicine), Provincial Key Supporting Disciplines (Intensive Care Medicine) and Medical Key Discipline Group (Geriatrics), Chief Scientist of Zhejiang Science and Technology Innovation Team "Intensive Care Medicine", and Director of Zhejiang ICU Quality Control Center. He enjoys the special allowance of the State Council, the national young experts with outstanding contribution to health planning, the national advanced workers, and the training target of leading talents in health in Zhejiang Province. He is the editor-in-chief of Chinese Electronic Journal of Geriatric Research and Prevention of Cardiovascular and Cerebrovascular Diseases. He won the second prize of Zhejiang Science and Technology Award, the first prize of Zhejiang Medicine and Health Science and Technology Award, many invention patents, utility model patents and computer software copyrights. He has published more than 100 academic papers, including Lancet Respir Med, Intensive Care Med, Critical Care and other TOP journals in the professional field. He has edited and co-edited more than 10 books. He is responsible for the development of China's Guidelines for Hemodynamic Monitoring and Support of Severe Infection and Infectious Shock (2009) and China's Guidelines for the Treatment of Severe Sepsis Septic Shock (2014), and participated in the development of many guidelines such as China's Guidelines for the Construction and Management of Intensive Care Intensive Unit (ICU).

2

Proposed Research Fields

(1) Basic and translational medical research on sepsis, focusing on the mechanisms of occurrence, early diagnosis and intervention strategies of multi-organ and system dysfunction caused by sepsis.

(2) Accurate monitoring and treatment of hemodynamics in critically ill patients, mechanisms of occurrence of multi-organ dysfunction, and support strategies.

Professor Jin Xiaoqing's Team

1

Mentor Profile

Chief Chinese medicine physician, doctoral supervisor, vice president of Zhejiang Hospital, the sixth batch of national old Chinese medicine experts academic experience succession instructor, Zhejiang Province national medical master, enjoys the special allowance of the State Council experts, Zhejiang Province combined Chinese and Western medicine geriatrics discipline leader. He is also the director of Chinese Acupuncture Society, vice president of Zhejiang Acupuncture Society, vice chairman of Zhejiang Medical Association Epidemiology and Evidence-based Medicine Committee, and executive editorial board member of Chinese Geriatrics Research Electronic Journal. His research interests are acupuncture analgesia and immunomodulation. He has presided over and participated in one key and one major special project of the Ministry of Science and Technology, undertaken one key project of Chinese medicine science and technology in Zhejiang Province, completed one major special project of science and technology in Zhejiang Province and two provincial fund projects, published more than 10 SCI papers, published five monographs, and won three science and technology awards in Zhejiang Province for his research results.

2 Proposed Research Fields

(1) Neurobiological mechanism of chronic pain and acupuncture analgesia.

(2) The application of artificial intelligence technology in the diagnosis and treatment of Parkinson's disease.

Professor Wan Shu‘s ’Team

1

Mentor Profile

He is a chief physician, professor, doctoral supervisor, vice president of Zhejiang Hospital, head of the brain center; high-level medical innovator of Zhejiang Province, reserve discipline leader of Zhejiang innovative discipline (neurotraumatology); member of the neurointerventional committee of Chinese Physicians Association, deputy secretary-general of the Yangtze River Delta Cerebrovascular Disease Specialty Alliance, executive director of Zhejiang Mathematical Medicine Society, precision diagnosis and treatment committee of cerebrovascular disease, etc.   In recent years, he has conducted more in-depth research on the pathophysiological mechanism of brain injury secondary to cerebral hemorrhage and subarachnoid hemorrhage, the pathophysiological mechanism of intracranial and external arterial stenosis, and the development and application of AI strategy platform for precise diagnosis and treatment of cerebrovascular diseases based on hemodynamic analysis; he has presided over more than 10 projects including National Natural Science Foundation of China, Provincial Natural Science Foundation of China, Provincial Key Research and Development Project and Provincial Major Science and Technology Program of Medicine and Health. He has published more than 40 academic papers in authoritative journals such as Signal Transduction and Targeted Therapy, Translational Stroke Research, Frontiers in Oncology, etc. as the first or corresponding author. He is the deputy editor-in-chief of Cardiovascular and Cerebrovascular Disease Prevention and Control, and the correspondence reviewer of National Natural Science Foundation of China and Neural Regen Res.

2

Proposed Research Fields

(1) Regulation of blood-brain barrier by microglia.

(2) Mechanistic studies of ischemic stroke.

(3) Secondary brain injury and neurological function repair after cerebral hemorrhage.

Professor Jun Huang's Team

1

Mentor Profile

Professor, PhD, Vice President of Zhejiang Hospital, Deputy Director of the Key Laboratory of the Ministry of Education for the Stability and Protection of Living Systems, Zhejiang University, Distinguished Professor of Zhejiang University, recipient of the National Outstanding Young Scientist Fund, selected as a Young Talent of the National Ten Thousand People Plan, a Young and Middle-aged Science and Technology Innovation Leader of the Ministry of Science and Technology, a Science and Technology Innovation Leader of the National Ten Thousand People Plan, and a Distinguished Expert of Zhejiang Province. He has been selected as one of the National Ten Thousand-Year Plan - Young Leading Talents in Science and Technology, the National Ten Thousand-Year Plan - Leading Talents in Science and Technology, and the Specially Appointed Expert of Zhejiang Province. He has been working on the mechanism of DNA damage repair in the development of tumor and aging process. In 2017, he won the First Prize of Natural Science of Zhejiang Province as the first author.

2

Proposed Research Fields

(1) Basic medicine.

(2) Cell biology.

(3) Biochemistry and molecular biology.

(4) Pharmacology.

Professor Tang Lijiang‘s Team

1

Mentor Profile

Chief physician, doctoral supervisor, assistant to the president of Zhejiang Hospital, director of the Department of Internal Medicine, director of the Cardiovascular Center, director of the Department of Cardiovascular Medicine and director of the electrocardiogram department, enjoys the special allowance of the State Council, the provincial "151 talents project", the provincial excellent physician, member of the Chinese Medical Association of cardiac electrophysiology and pacing branch, the Chinese Medical Association of Cardiovascular Diseases Branch of the geriatric group He is a member of the Cardiovascular Disease Branch of the Chinese Medical Association, a deputy director of the Hypertension Branch of the Chinese Medical Association, a deputy director of the Cardiovascular Disease Branch of the Zhejiang Medical Association, a deputy director of the Cardiovascular Society of Zhejiang Province, and a deputy director of the Cardiac Electrophysiology and Pacing Branch of Zhejiang Province. He is mainly engaged in the diagnosis and treatment of heart disease access, prevention and pathogenesis of coronary heart disease research, has studied and exchanged in the United States for 2.5 years, published and exchanged more than 100 articles, undertook a total of 13 national natural funds and provincial/departmental/municipal projects, won a total of 5 provincial and municipal scientific and technological progress awards.

2

Proposed Research Fields

(1) Research on the mechanism of atherogenesis and development of atherosclerosis (the mechanism of inflammation, platelets, and hydrodynamics in atherosclerosis).

(2) Research on the mechanism of the development of aortic dilation-type diseases (the mechanism of the role of inflammation, platelets, and fluid dynamics in aortic dilation).

(3) New model of precise diagnosis and treatment of coronary heart disease based on artificial intelligence technology.

Professor Cai Guolong's Team

1

Mentor Profile

Chief Physician, Doctoral Supervisor of Zhejiang University, Director of Department of Science and Education, Director of ICU (II) of Zhejiang Hospital, Young and Middle-aged Expert with Outstanding Contribution in Zhejiang Province, High-level Talent of Zhejiang Health, 151 Talent of Zhejiang Province, currently the main social positions are: Deputy Director of Critical Care Medicine Quality Control Center of Zhejiang Provincial Health Department, Member and Secretary of Critical Care Medicine Branch of Zhejiang Medical Association, Reserve Discipline of Critical Care Medicine of National Key Clinical Specialties He is also the director of the Critical Care Branch of the Chinese Geriatrics Society, and the leader of the key innovative discipline "Sepsis" in Zhejiang Province. His main achievements and contributions include: publishing more than 50 scientific papers and co-editing 5 books. In recent years, he has presided over a sub-project of the support program of the Ministry of Science and Technology, a major project of the provincial leader and a joint project of the provincial ministry, and two provincial natural funds; he has won a second prize of science and technology of Zhejiang Province, a first prize and a third prize of health science and technology innovation award, and a first prize of Chinese medicine science and technology of Zhejiang Province.

2

Proposed Research Fields

(1) Developing early identification technology for sepsis through multi-center clinical trials.

(2) Development of novel biomarkers for early warning prognosis of sepsis and clinical techniques.

(3) Develop microcirculation technology application based on SDF technology by establishing sublingual microcirculation simulation model combined with AI technology and microcirculation network function analysis technology.

Professor Mao Genxiang's Team

1

Mentor Profile

Researcher, doctoral supervisor, deputy director of Zhejiang Institute of Geriatrics, deputy director of Zhejiang Key Laboratory of Geriatrics, postdoctoral fellow of Johns Hopkins University School of Medicine, member of Anti-Aging Branch of Chinese Society of Gerontology and Geriatrics, executive member of the Third Academic Division of Tumor Prevention and Control Branch of Chinese Society of Geriatric Health Care Medicine, member of Anti-Cancer Drug Committee of Chinese Anti-Cancer Association, member of Marine Drug Committee of Zhejiang Pharmaceutical Society, member of Pharmaceutical Society of Zhejiang Province. He is also a member of the Youth Sub-Committee of the Drug Toxicology Committee of Zhejiang Pharmaceutical Society, a standing member of the Natural Environment and Recreation Committee of Zhejiang Rehabilitation Medicine Association, a member of the Editorial Board of the Chinese Electronic Journal of Geriatric Research, and a youth member of the Editorial Board of China Modern Applied Pharmacology; he is responsible for two national natural projects, one international cooperation project of Zhejiang Public Welfare Technology Application Research Program. In the past 5 years, he has published 25 SCI papers as the first/corresponding author (9 papers in Zone 1 and Zone 2 of Chinese Academy of Sciences); he has obtained 3 authorized invention patents. He was awarded the third prize of science and technology of Zhejiang Pharmaceutical Society and the second prize of medicine and health science and technology of Zhejiang Province as the first completer. He has been selected as one of the health innovation talents training targets in Zhejiang Province.

2

Proposed Research Fields

(1) Molecular mechanism of DNA damage repair and cancer development.

(2) Research on aging mechanism and intervention.

(3) Anti-human cytomegalovirus (HCMV) drug research.

Professor Liu Xiaoli's Team

1

Mentor Profile

M.D., Chief Physician, Deputy Director of Administration, Department of Neurology, Zhejiang Hospital. He is a visiting scholar at Harvard University's Brigham and Women's Hospital Neurology Center; a visiting scholar at the Royal Melbourne Hospital Brain Center in Australia. He is the head of the Department of Geriatric Neurology, a key discipline at the hospital level. He is currently a member of the Geriatric Neurology Group of the Geriatrics Branch of the Chinese Medical Association, a youth member of the Geriatrics Branch of the Chinese Medical Association, a youth member of the Neurology Committee of the Zhejiang Medical Association, a member of the Neurology Branch of the Zhejiang Medical Association, a deputy director of the Neuroimmunology Group of the Zhejiang Medical Association, a member and secretary of the Geriatrics Branch of the Zhejiang Medical Association; a member and secretary of the Chinese Journal of Geriatric Electronic Research, the Editorial board member of Journal of Cardiovascular and Cerebrovascular Diseases Prevention and Control, and Journal of Practical Geriatrics. At present, he is working on one major research and development program sub-project of the Ministry of Science and Technology of China, one major science and technology program of the National Health and Health Commission Scientific Research Fund - Zhejiang Province, one project of the Zhejiang Provincial Central Authority, one project of the Zhejiang Provincial Science and Technology Department, and many projects at the department and bureau level. He has published more than 30 papers, of which more than 10 are of high quality and high level; he has been selected as a training candidate for high-level medical talents in provincial health.

2

Proposed Research Fields

(1) The regulation mechanism of autonomic intracerebral circuit in cardiovascular diseases.

(2) The regulatory mechanism of microglia on autonomic function in neurodegenerative diseases.

(3) The regulation mechanism of blood-brain barrier homeostasis.

Professor Jiang Hao's Team

1

Mentor Profile

D. in Oncology, Deputy Director of Department of Oncology, Zhejiang Hospital. He is an expert in basic and applied basic research fund review in Guangdong Province, an expert in natural science fund review in Zhejiang Province, a 3060 reserve discipline leader and 1530 backbone top-notch talent in Zhejiang Hospital. He is currently a member of the Standing Committee of Zhejiang Provincial Branch of Tumor Thermotherapy Committee of Chinese Anti-Cancer Association, Vice Chairman of Youth Committee of Integrative Tumor Committee of Zhejiang Provincial Anti-Cancer Association, member of Tumor Chemotherapy and Biotherapy Branch of Zhejiang Provincial Medical Association, member of Tumor Prevention and Control Committee of Zhejiang Provincial Preventive Medicine Association, member of Tumor Internal Medicine Committee of Zhejiang Provincial Anti-Cancer Association, member of Cellular Immunotherapy Committee of Zhejiang Provincial Society of Translational Medicine, and member of Zhejiang Mathematical Medicine Association. Member of Zhejiang Provincial Society of Translational Medicine, Member of Zhejiang Provincial Society of Mathematical Medicine, Member of Tumor Data Intelligence Physiotherapy Committee, Member of Chinese Geriatric Health Care Medical Research Society Tumor Prevention and Control Branch, Member of Chinese Medical Education Association Tumor Metastasis Committee, Young Member of Zhejiang Provincial Anti-Cancer Association Lung Cancer Committee, Young Member of Zhejiang Provincial Anti-Cancer Association Tumor Targeting and Cell Therapy Committee, Member of Zhejiang Provincial Health Journalists Association Photography Committee. He is also a member of the Photography Committee of Zhejiang Health Journalists Association. Editorial board member of Chinese Electronic Journal of Geriatric Research. He has presided over 2 projects of National Natural Science Foundation of China, 1 project of Zhejiang Provincial Natural Science Foundation of China, 2 projects of Zhejiang Provincial Medical and Health Science and Technology Program, and 1 project of Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program. He has published more than 40 academic papers at home and abroad, including 15 SCI papers with first or corresponding authorship, co-edited 2 monographs on radiation oncology, obtained 1 authorized invention patent, and won 1 second prize and 1 third prize of Zhejiang Provincial TCM Science and Technology Award. He has been selected as one of the training candidates for high-level talents in Zhejiang Province.

2

Proposed Research Fields

(1) Research on the mechanism of effective active ingredients of traditional Chinese medicine in synergistic anti-targeted drug resistance and new drug development; (2) Basic and clinical research on the improvement of tumor immune microenvironment and efficacy and toxicity reduction in radiotherapy and targeted immunotherapy by traditional Chinese medicine; (3) Research on DNA damage mechanism and post-translational modification function.

Prof. Li Li‘s ’Team

1

Mentor Profile

D., chief physician, master's degree, deputy director of ICU (I) of Zhejiang Hospital. She is a youth member of the Intensive Care Medicine Branch of the Chinese Physicians Association, a youth deputy director of the Intensive Care Medicine Branch of the Zhejiang Medical Association, and a member of the Intensive Care Medicine Branch of the Zhejiang Society of Integrative Medicine. He is a high-level health innovation talent of Zhejiang Province, the second level of 151 talent project of Zhejiang Province, the first session of Zhejiang Province medical new talent, core member of Zhejiang Province "critical care medicine" science and technology innovation team, and 3060 reserve discipline leader of Zhejiang Hospital. He is an expert of National Natural Science Foundation of China and Science and Technology Department of Zhejiang Province. He has conducted basic and translational medical research on sepsis, mainly focusing on the regulatory mechanisms of inflammatory immune-mediated cellular autophagy and exosomes involved in myocardial injury in sepsis. He has presided over or participated in national science and technology major projects, health industry research projects, National Natural Science Foundation of China projects, Zhejiang Provincial Natural Science Foundation key projects, and National Health Care Commission key projects. He has published in Lancet Respir Med, Critical Care, Respiratory Research, Eur J Clin Invest, Journal of Critial Care and other prestigious journals as first or corresponding (including co-) author. He was awarded two second prizes for scientific and technological progress in Zhejiang Province, and one first prize and one second prize for medical and health innovation in Zhejiang Province. He participated in the formulation of the Chinese Guidelines for the Treatment of Severe Sepsis/Septic Shock (2014) (cited more than 1200 times) and the Expert Consensus on the Treatment of Acute Severe Pancreatitis in Zhejiang Province. He also edited the national higher education planning textbook "Critical Care Medicine" and "Training Textbook for Specialist Qualification in Critical Care Medicine in China".

2

Proposed Research Fields

Basic and translational medical research on myocardial injury in sepsis.

Contact us

 CONTACT US

Scan

to apply

The hospital accepts applications for postdoctoral fellowship year-round

Applicants can contact their supervisors in advance

After reaching a preliminary agreement on recruitment

Submit application materials according to the procedure

Contact Department: Postdoctoral Management Office of Zhejiang Hospital

Address: No. 12, Lingyin Road, West Lake District, Hangzhou, Zhejiang Province, China

Post code: 310013     

Contact Person: Ms. Zhu

Email: 490832240@qq.com

Tel: 0571-81595007  

Editor: Ting Review: Jing

Source: Department of Organization and Personnel, Postdoctoral Management Office

By: Organization and Personnel Department, Zhu Ruichen

This article is the original of Zhejiang Hospital, please indicate the source "Zhejiang Hospital" Official Account

Zhejiang Hospital Lingyin Area

Address: No. 12, Lingyin Road, Hangzhou 

Zhejiang Hospital Sandun Area

Address:No.1229 Gudun Road, Hangzhou 

Tel:0571-87987373 

Website:http://zjhospital.com.cn/

Cell phone appointment.

Zhejiang Hospital subscription number/Official Account, Zhejiang Government APP, Alipay, Zhejiang appointment registration, etc.

Website appointment:

http://:guahao.zjol.com.cn

http://www.zj12580.cn

http://yiyuan.96365.com

Telephone booking: 114, 116114, 12580, 96365